Comparative functional survival and equivalent annual cost of 3 long-lasting insecticidal net (LLIN) products in Tanzania: A randomised trial with 3-year follow up

Lena M Lorenz, John Bradley, Joshua Yukich, Dennis J Massue, Zawadi Mageni Mboma, Olivier Pigeon, Jason Moore, Albert Kilian, Jo Lines, William Kisinza, Hans J Overgaard and Sarah J Moore

PLOS Medicine, 2020, vol. 17, issue 9, 1-18

Abstract: Background: Two billion long-lasting insecticidal nets (LLINs) have been procured for malaria control. A functional LLIN is one that is present, is in good physical condition, and remains insecticidal, thereby providing protection against vector-borne diseases through preventing bites and killing disease vectors. The World Health Organization (WHO) prequalifies LLINs that remain adequately insecticidal 3 years after deployment. Therefore, institutional buyers often assume that prequalified LLINs are functionally identical with a 3-year lifespan. We measured the lifespans of 3 LLIN products, and calculated their cost per year of functional life, to demonstrate the economic and public health importance of procuring the most cost-effective LLIN product based on its lifespan. Methods and findings: A randomised double-blinded trial of 3 pyrethroid LLIN products (10,571 nets in total) was conducted at 3 follow-up points: 10 months (August–October 2014), 22 months (August–October 2015), and 36 months (October–December 2016) among 3,393 households in Tanzania using WHO-recommended methods. Primary outcome was LLIN functional survival (LLIN present and in serviceable condition). Secondary outcomes were (1) bioefficacy and chemical content (residual insecticidal activity) and (2) protective efficacy for volunteers sleeping under the LLINs (bite reduction and mosquitoes killed). Median LLIN functional survival was significantly different between the 3 net products (p = 0.001): 2.0 years (95% CI 1.7–2.3) for Olyset, 2.5 years (95% CI 2.2–2.8) for PermaNet 2.0 (hazard ratio [HR] 0.73 [95% CI 0.64–0.85], p = 0.001), and 2.6 years (95% CI 2.3–2.8) for NetProtect (HR = 0.70 [95% CI 0.62–0.77], p

Date: 2020
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003248 (text/html)
https://journals.plos.org/plosmedicine/article/fil ... 03248&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pmed00:1003248

DOI: 10.1371/journal.pmed.1003248

Access Statistics for this article

More articles in PLOS Medicine from Public Library of Science
Bibliographic data for series maintained by plosmedicine ().